What to know about viral menopause treatment trend (Good Morning America)
Tier 3: Supporting source (media, company, or community), never used alone for health claims
Publisher: Good Morning America (ABC News) · Published: May 6, 2026 ·
Accessed: August 7, 2026
Visit the source ↗
Claims this source supports
- The viral trend combines Allegra (fexofenadine, an allergy drug) and Pepcid (famotidine, an ulcer/acid-reflux drug); both have antihistamine effects, but there is no real data or studies that link histamine and menopause.
- Menopause symptoms are believed to be a result of fluctuations in hormones, not histamine.
- Potential side effects and risks of the combination include drug interactions, sedation, confusion, dizziness, headache, lowered platelets, reduced vitamin D, and even hot flashes or heart rhythm problems.
- Evidence-backed options include menopause-certified providers (menopause.org), hormone therapy for low-risk women within 10 years of menopause and under 60, nonhormonal drugs such as fezolinetant (Veozah) or paroxetine (Paxil), and lifestyle measures including exercise, stress management, cognitive behavioral therapy, and a healthy diet.